OMC
EUCRW

Old Mission Capital’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Old Mission Capital’s Portfolio EUCRW Stock Details EUCRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,042
Closed -$891 – 1837
2022
Q4 		$891 Buy
+16,042
New +$571 ﹤0.01% 1366
2022
Q3 		– Sell
-17,392
Closed -$1K – 1506
2022
Q2 		$1K Buy
17,392
+6,573
+61% +$1.06K ﹤0.01% 1382
2022
Q1 		$2K Buy
+10,819
New +$4.39K ﹤0.01% 1313

Other funds holding EUCRW

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Old Mission Capital's EUCRW Position: Q1 2023 in Review

Old Mission Capital sold out of Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) in Q1 2023, closing a stake of 16,042 shares — an estimated $891 sold.

Old Mission Capital first reported a position in EUCRW in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q1 2022. 22 funds tracked by Wall St. Rank hold EUCRW as of Q1 2023.

  • Old Mission Capital reported no remaining Eucrates Biomedical Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Old Mission Capital sold 16,042 Eucrates Biomedical Acquisition Corp. Warrant shares in Q1 2023, an estimated $891.
  • Old Mission Capital first reported a position in Eucrates Biomedical Acquisition Corp. Warrant in Q1 2022 and held it in 3 quarters.
  • Old Mission Capital's Eucrates Biomedical Acquisition Corp. Warrant position peaked at $2K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Warrant as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.